6 hours ago
Gypsy Rose Blanchard tells PEOPLE exclusively that partner Ken Urker overdosed after his death at age 34
Blanchard says she does not know what he took or whether the overdose was intentional
She says that Urker was "an amazing father" who will "forever be my soulmate"
Gypsy Rose Blanchard is breaking her silence after the death of her partner, Ken Urker, revealing exclusively to PEOPLE that she believes that he overdosed.
"I don't know if it was intentional or not," Blanchard tells PEOPLE exclusively. "He was not in a good state of mind lately."
#overdosed #death
Blanchard says she does not know what he took or whether the overdose was intentional
She says that Urker was "an amazing father" who will "forever be my soulmate"
Gypsy Rose Blanchard is breaking her silence after the death of her partner, Ken Urker, revealing exclusively to PEOPLE that she believes that he overdosed.
"I don't know if it was intentional or not," Blanchard tells PEOPLE exclusively. "He was not in a good state of mind lately."
#overdosed #death
14 hours ago
Busy Philipps tells PEOPLE her oncologist confirmed her latest scan was clear after she was diagnosed with a brain tumor
Doctors discovered the rare tumor during a full-body MRI in February
Philipps underwent two surgeries and did not need chemotherapy or radiation
Busy Philipps shared a positive update amid her ongoing health journey after she was diagnosed with a brain tumor earlier this year.
"I chatted with my oncologist today," the Cupertino star, 47, tells PEOPLE exclusively at the Wednesday, Sept. 30, premiere of the CBS show in New York City. The Silicon Valley-set legal drama was her doctor's preferred topic of conversation, Philipps shars.
#tumor #people
Doctors discovered the rare tumor during a full-body MRI in February
Philipps underwent two surgeries and did not need chemotherapy or radiation
Busy Philipps shared a positive update amid her ongoing health journey after she was diagnosed with a brain tumor earlier this year.
"I chatted with my oncologist today," the Cupertino star, 47, tells PEOPLE exclusively at the Wednesday, Sept. 30, premiere of the CBS show in New York City. The Silicon Valley-set legal drama was her doctor's preferred topic of conversation, Philipps shars.
#tumor #people
15 hours ago
Jelly Roll and Bunnie XO are putting one of their Nashville-area homes up for sale after finalizing their divorce. The Franklin, Tennessee, estate now carries a price of just under $7 million. The former couple listed the property after reaching a settlement over their ******* ets.
Real estate sources told TMZ that the couple listed the home on Wednesday. The estate was custom-built and features over 10 acres and over 7,000 square feet of living area. The property has five bedrooms and seven bathrooms. It also offers views of the Tennessee countryside.
The home includes a chef's kitchen and a media den that looks over a glass-walled automotive showroom. On the outside, the estate has a covered porch and an outdoor kitchen. It also has outdoor dining and living ******* es. The outdoor ******* e is completed by a resort-style pool.
The listing is held by Erik Levin of Benchmark Realty and Greg Sanford of Greg Sanford Real Estate. The sale comes after Jelly Roll and Bunnie finalized their divorce in July. Court documents obtained by TMZ show that the former couple reached a settlement covering their aircraft, cars, homes, and intellectual property. Jelly Roll also agreed to give Bunnie a one-time lump-sum payment.
It was previously reported that movers appeared at the property in June. Exclusive photos showed a large moving truck outside while workers appeared to remove items from the home. Jelly Roll filed for divorce in May, and sources with direct knowledge said the split came from a mutual decision handled privately. Jelly Roll and Bunnie married in August 2016 after meeting the year before.
#bunnie #property #tennessee
Real estate sources told TMZ that the couple listed the home on Wednesday. The estate was custom-built and features over 10 acres and over 7,000 square feet of living area. The property has five bedrooms and seven bathrooms. It also offers views of the Tennessee countryside.
The home includes a chef's kitchen and a media den that looks over a glass-walled automotive showroom. On the outside, the estate has a covered porch and an outdoor kitchen. It also has outdoor dining and living ******* es. The outdoor ******* e is completed by a resort-style pool.
The listing is held by Erik Levin of Benchmark Realty and Greg Sanford of Greg Sanford Real Estate. The sale comes after Jelly Roll and Bunnie finalized their divorce in July. Court documents obtained by TMZ show that the former couple reached a settlement covering their aircraft, cars, homes, and intellectual property. Jelly Roll also agreed to give Bunnie a one-time lump-sum payment.
It was previously reported that movers appeared at the property in June. Exclusive photos showed a large moving truck outside while workers appeared to remove items from the home. Jelly Roll filed for divorce in May, and sources with direct knowledge said the split came from a mutual decision handled privately. Jelly Roll and Bunnie married in August 2016 after meeting the year before.
#bunnie #property #tennessee
16 hours ago
Davante Adams has NFL money, but one of his favorite flexes apparently can't be bought.
The Los Angeles Rams wide receiver showed off his Taco Bell Purple Card during an appearance on FanDuel TV's Up & Adams, revealing that the personalized card gives him essentially unlimited purchasing power at the fast-food chain.
Even more exclusive: Adams says only two people currently have one. The other is Kevin Hart.
COMPLEX SHOP: Shop the brands you love, anytime and anywhere. Uncover what's next. Buy. Collect. Obsess.
"It's got my name on the back, so if anybody tries to rob me, you'll never be able to use it," Adams said while displaying the card. "It's like a credit card. This Purple Card is basically like a black card, but it's purple and can only be used at Taco Bell. But it is unlimited."
#card #adams #shop #unlimited
The Los Angeles Rams wide receiver showed off his Taco Bell Purple Card during an appearance on FanDuel TV's Up & Adams, revealing that the personalized card gives him essentially unlimited purchasing power at the fast-food chain.
Even more exclusive: Adams says only two people currently have one. The other is Kevin Hart.
COMPLEX SHOP: Shop the brands you love, anytime and anywhere. Uncover what's next. Buy. Collect. Obsess.
"It's got my name on the back, so if anybody tries to rob me, you'll never be able to use it," Adams said while displaying the card. "It's like a credit card. This Purple Card is basically like a black card, but it's purple and can only be used at Taco Bell. But it is unlimited."
#card #adams #shop #unlimited
17 hours ago
Robert Hays is opening up about losing his Malibu home and belongings in the devastating 2018 fire, escaping with only a few items
He and his now-wife Gina relocated to Hawaii shortly after, starting a new chapter in their lives
Hays will join the Airplane! live tour this fall, sharing behind-the-scenes stories and rare footage with fans
Actor Robert Hays is recounting the devastating Malibu fires that saw him lose his home and belongings and start a new life in Hawaii.
Speaking to PEOPLE in a recent exclusive interview, Hays, 79, shared how he fled the home with little more than a pair of cargo shorts.
#hays #belongings #devastating
He and his now-wife Gina relocated to Hawaii shortly after, starting a new chapter in their lives
Hays will join the Airplane! live tour this fall, sharing behind-the-scenes stories and rare footage with fans
Actor Robert Hays is recounting the devastating Malibu fires that saw him lose his home and belongings and start a new life in Hawaii.
Speaking to PEOPLE in a recent exclusive interview, Hays, 79, shared how he fled the home with little more than a pair of cargo shorts.
#hays #belongings #devastating
18 hours ago
Michael Douglas' "One **** uva Ride," out next week, is one of the most earnest and entertaining celebrity memoirs you're likely to read, covering his career as an Oscar-winning actor and producer along with his occasionally **** py personal life — both in incredible detail.
But the book almost didn't make it to bookstores on time, TheWrap can exclusively report.
According to insiders with knowledge of the situation, it nearly missed its deadline, which would have been catastrophic for publisher Grand Central Publishing, as the book was set to publish on Oct. 6. A multimillion-dollar advance had been paid to Douglas, with foreign rights sold in 25 countries and an extensive media tour plotted that included interviews with the New York Times, **** ociated Press and NPR, as well as appearances on shows hosted by Jimmy Kimmel, Bill Maher and Joe Rogan (plus, of course, the hosts of "The View"). The pressure was on.
"We knew Michael's book was going to go far and push boundaries," one insider said. "But we didn't expect it to go as far as it did, and to have that level of detail about his personal life and receipts for the most unbelievably wild and hilarious stories."
In the book, Douglas tells stories that he hasn't ever shared, revealing new details about some of his most famous productions, along with previously untold stories from private life (both, as you can imagine, are full of revelatory, drop-your-book-in-your-lap moments). It's a hoot.
#along #helluva
But the book almost didn't make it to bookstores on time, TheWrap can exclusively report.
According to insiders with knowledge of the situation, it nearly missed its deadline, which would have been catastrophic for publisher Grand Central Publishing, as the book was set to publish on Oct. 6. A multimillion-dollar advance had been paid to Douglas, with foreign rights sold in 25 countries and an extensive media tour plotted that included interviews with the New York Times, **** ociated Press and NPR, as well as appearances on shows hosted by Jimmy Kimmel, Bill Maher and Joe Rogan (plus, of course, the hosts of "The View"). The pressure was on.
"We knew Michael's book was going to go far and push boundaries," one insider said. "But we didn't expect it to go as far as it did, and to have that level of detail about his personal life and receipts for the most unbelievably wild and hilarious stories."
In the book, Douglas tells stories that he hasn't ever shared, revealing new details about some of his most famous productions, along with previously untold stories from private life (both, as you can imagine, are full of revelatory, drop-your-book-in-your-lap moments). It's a hoot.
#along #helluva
18 hours ago
The Chloé girl was out in force for the house's spring 2027 show in Paris on Wednesday, and the front row offered almost as much of a study in the brand's bohemian shoe wardrobe as the runway itself.
Maude Apatow went full Chloé in the label's chunky Talis platform clogs, while Soo Joo Park and Natalia Bryant made a case for keeping sandals in rotation well past summer, wearing theirs with stockings.
More from WWD
A$AP Rocky's Newest Puma Styles Hit the AWGE Runway at Paris Fashion Week
EXCLUSIVE: Kai Nesselrath's Carven Is About Architecture, Paris and Women Who Are Doers
#runway #maude #park #bryant
Maude Apatow went full Chloé in the label's chunky Talis platform clogs, while Soo Joo Park and Natalia Bryant made a case for keeping sandals in rotation well past summer, wearing theirs with stockings.
More from WWD
A$AP Rocky's Newest Puma Styles Hit the AWGE Runway at Paris Fashion Week
EXCLUSIVE: Kai Nesselrath's Carven Is About Architecture, Paris and Women Who Are Doers
#runway #maude #park #bryant
18 hours ago
Fiona Hepler Lowe, the daughter of actor Chad Lowe, has tragically died at age 13.
"We are deeply heartbroken by the loss of our beloved Fiona," the ER actor and his wife, producer Kim Painter, said in a statement to People on Tuesday, September 29. They described Fiona as a "loving young girl who was smart, creative, and loved to dance," adding that she was "adored by her sisters and she was deeply loved by her parents. In fact, she was the light of our lives."
More from StyleCaster
A New Twilight Perfume Is Here & It Smells Just Like How the Love Story Feels (Exclusive)
Kate Hudson's Go-To Hair Brand Is Now at Target Beauty Studio-These Are the Products We Can't Live Without
#loved #painter
"We are deeply heartbroken by the loss of our beloved Fiona," the ER actor and his wife, producer Kim Painter, said in a statement to People on Tuesday, September 29. They described Fiona as a "loving young girl who was smart, creative, and loved to dance," adding that she was "adored by her sisters and she was deeply loved by her parents. In fact, she was the light of our lives."
More from StyleCaster
A New Twilight Perfume Is Here & It Smells Just Like How the Love Story Feels (Exclusive)
Kate Hudson's Go-To Hair Brand Is Now at Target Beauty Studio-These Are the Products We Can't Live Without
#loved #painter
19 hours ago
With 8.5 million people spread over just 300 square miles, New York is the most populous city in America. Home to Broadway, Wall Street, the Met, Lincoln Center, Carnegie Hall, the Comedy Cellar and, of course, the news media, New York is where the conversation starts and ends.
More from Variety
Doc Society Announces Fund for Films 'In Service of Better Futures,' Zohran Mamdani Project Among First Supported Features (EXCLUSIVE)
Anne Hathaway Would Rather Have Another Knicks Championship Over a Second Oscar
'Verity' Review: Dakota Johnson and Anne Hathaway Drift Through Another Listless Colleen Hoover Adaptation
#anne #hathaway
More from Variety
Doc Society Announces Fund for Films 'In Service of Better Futures,' Zohran Mamdani Project Among First Supported Features (EXCLUSIVE)
Anne Hathaway Would Rather Have Another Knicks Championship Over a Second Oscar
'Verity' Review: Dakota Johnson and Anne Hathaway Drift Through Another Listless Colleen Hoover Adaptation
#anne #hathaway
19 hours ago
What do you get when you combine a hilarious actor, a popular social media influencer, and some furry best friends with a well-known brand? A hilarious series of videos that puts a playful spin on an everyday reality of being a cat parent that's sure to make you laugh.
Actor ***** ail Nanjiani and viral content creator Jordan Howlett teamed up for the purrfect collab that will have you running to your nearest pet store to stock up on Tidy Cats litter.
Kumail Nanjiani had some time earlier this week to sit down with The Blast to talk exclusively about the new partnership and collaboration, his upcoming roles, and what he loves about being a cat dad.
Tidy Cats
Kumail and Jordan recently joined forces to help put a stop to a crime every cat parent is well aware of – bad litter. The cat litter brand from Purina just launched the Special Litter Unit, a three-part crime series starring ***** ail and Jordan. Fans can follow the case online and New York City cat lovers can join the investigation in person on Friday, Oct. 2 for a one-day pop-up experience that features some loveable adoptable feline agents.
#actor
Actor ***** ail Nanjiani and viral content creator Jordan Howlett teamed up for the purrfect collab that will have you running to your nearest pet store to stock up on Tidy Cats litter.
Kumail Nanjiani had some time earlier this week to sit down with The Blast to talk exclusively about the new partnership and collaboration, his upcoming roles, and what he loves about being a cat dad.
Tidy Cats
Kumail and Jordan recently joined forces to help put a stop to a crime every cat parent is well aware of – bad litter. The cat litter brand from Purina just launched the Special Litter Unit, a three-part crime series starring ***** ail and Jordan. Fans can follow the case online and New York City cat lovers can join the investigation in person on Friday, Oct. 2 for a one-day pop-up experience that features some loveable adoptable feline agents.
#actor
11 days ago
IonQ (IONQ) is a quantum computing company whose stock has been a favorite among speculative buyers and high-volatility traders, thanks to its high beta (3.30 over the last 60 months) and news-driven price action. It's not uncommon to see the stock swinging by double-digit percentages around news, earnings, partnership announcements, or sector sentiment shifts.
But today, we have a rare event.
Domino's Pizza Stock Is Dirt Cheap, With 30% Potential Upside - What's the Best Play?
Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, ***** ysis, and headlines.
IonQ, the volatile quantum stock, is now sitting at 0% IV rank. That means options on IONQ are priced much cheaper than they have been historically, creating an opportunity to go long.
#quantum #high #pizza #best
But today, we have a rare event.
Domino's Pizza Stock Is Dirt Cheap, With 30% Potential Upside - What's the Best Play?
Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, ***** ysis, and headlines.
IonQ, the volatile quantum stock, is now sitting at 0% IV rank. That means options on IONQ are priced much cheaper than they have been historically, creating an opportunity to go long.
#quantum #high #pizza #best
11 days ago
Is there any investment market segment more debated than gold (XAUUSD)? I'm not sure there is. We have "gold bugs," including those who see the yellow metal as the ***** et to own when the world goes haywire.
Then, there are the "we're going back on the gold standard" types. The ones that preceded crypto bros in believing fiat currencies weren't for this world. It follows that gold would return to its former role as the reserve currency.
Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market ***** ysis you won't find anywhere else.
Of course, there are also plenty of investors who don't really think about gold investing very much, and who will simply trade it when there's a good opportunity. I'm in this camp.
Financial media pundits routinely tout gold as some sort of bulletproof allocation. Inflation worries? Own gold. Currency debasement? Own gold. Want your kitchen to be decorated like the Oval Office? You'll need a lot of gold.
#Gold #free #barchart #brief
Then, there are the "we're going back on the gold standard" types. The ones that preceded crypto bros in believing fiat currencies weren't for this world. It follows that gold would return to its former role as the reserve currency.
Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market ***** ysis you won't find anywhere else.
Of course, there are also plenty of investors who don't really think about gold investing very much, and who will simply trade it when there's a good opportunity. I'm in this camp.
Financial media pundits routinely tout gold as some sort of bulletproof allocation. Inflation worries? Own gold. Currency debasement? Own gold. Want your kitchen to be decorated like the Oval Office? You'll need a lot of gold.
#Gold #free #barchart #brief
12 days ago
LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible AT&T wireless and fiber customers across 11 states. Customers must be 18 or older, and some services have additional eligibility and state restrictions. A nationwide expansion planned for January 2027 would extend eligibility beyond 100 million customers.
The $19 monthly membership fee is waived, but customers must enroll. Visits, prescriptions, and other services remain separately payable. For LifeMD, Inc. (NASDAQ:LFMD), the opportunity is converting access to a large audience into recurring demand for paid care.
The partnership gives LifeMD, Inc. (NASDAQ:LFMD) a distribution channel through the website, mobile app and customer-benefits program of AT&T Inc. (NYSE:T). Reaching customers through an established relationship could reduce reliance on advertising and lower acquisition costs per paying patient.
Removing the membership charge also reduces the financial commitment required to try the service. Announced visit prices start at $29 for message-based care, $49 for urgent and primary care video visits, and $79 for specialty care. Customers may use insurance, Medicare, or discounted cash-pay rates for visits and prescriptions.
LifeMD, Inc. (NASDAQ:LFMD) could benefit from repeat consultations and prescription fulfillment when clinically appropriate. Primary care, chronic-condition management and other services create opportunities for continuing patient relationships. If satisfied patients return, the revenue earned over those relationships could exceed the cost of acquiring and serving them.
#Services
The $19 monthly membership fee is waived, but customers must enroll. Visits, prescriptions, and other services remain separately payable. For LifeMD, Inc. (NASDAQ:LFMD), the opportunity is converting access to a large audience into recurring demand for paid care.
The partnership gives LifeMD, Inc. (NASDAQ:LFMD) a distribution channel through the website, mobile app and customer-benefits program of AT&T Inc. (NYSE:T). Reaching customers through an established relationship could reduce reliance on advertising and lower acquisition costs per paying patient.
Removing the membership charge also reduces the financial commitment required to try the service. Announced visit prices start at $29 for message-based care, $49 for urgent and primary care video visits, and $79 for specialty care. Customers may use insurance, Medicare, or discounted cash-pay rates for visits and prescriptions.
LifeMD, Inc. (NASDAQ:LFMD) could benefit from repeat consultations and prescription fulfillment when clinically appropriate. Primary care, chronic-condition management and other services create opportunities for continuing patient relationships. If satisfied patients return, the revenue earned over those relationships could exceed the cost of acquiring and serving them.
#Services
12 days ago
Elon Musk has never shied away from ambitious timelines, and his most recent one connects two companies directly together. In a post on X dated September 13, Musk stated that he is "highly confident" that **** e Exploration Technologies Corp. (NASDAQ:SPCX) will transport NVIDIA Corporation (NASDAQ:NVDA) Vera Rubin NVL72 AI computers into orbit next year, repeating a plan that has already moved both companies' stock this year.
The comment strengthens **** eX's Starmind concept, which aims to establish AI data centers in orbit rather than on the ground. The first satellite, named Starmind AI1, will carry a **** e-optimized version of NVIDIA's Vera Rubin NVL72 rack-scale system. The standard terrestrial NVL72 combines 72 Rubin GPUs and 36 Vera CPUs, although **** eX and NVIDIA have not disclosed the final configuration of the orbital version. **** e Exploration Technologies Corp. (NASDAQ:SPCX) plans to launch the satellite in the fourth quarter of 2027 and reach substantial scale by 2028. Musk's plan isn't new; during **** eX's first earnings conference as a public company in August, he stated that the company would build exclusively on NVIDIA hardware in the future, calling the Vera Rubin architecture the best available AI computer design.
Musk's central point is that **** e is, in the long run, the most cost-effective area to develop AI computing. He cites solar power availability in orbit as a crucial advantage, and estimates that within two to three years, **** e might become the lowest-cost place for AI computing in general, describing the orbital architecture as simpler, less expensive, denser, and lighter than a standard data-center rack. Not everyone believes the physics and economics will align on Musk's timeframe. Microsoft President Brad Smith has publicly questioned the broader concept, telling reporters that he would be surprised if companies actually transferred computation from land to low-Earth orbit.
For NVIDIA Corporation (NASDAQ:NVDA), the read-through is simple: **** e-based computing would represent a new, if early-stage and speculative, source of demand for its Vera Rubin platform, on top of the company's strong position in terrestrial AI infrastructure. According to some **** yst models, **** eX accounts for approximately 5% of NVIDIA's revenue.
SpaceX's reasoning is more convoluted. The plan is entirely dependent on the success of Starship, **** eX's next-generation rocket system, which still needs to demonstrate its capacity to handle launch frequency and reliability on the scale Musk describes. When Musk said during **** eX's August earnings call that the company would build its future AI infrastructure exclusively on NVIDIA, NVDA shares rose more than 4%, while **** eX's shares fell more than 10% before paring losses, reflecting investor concerns about execution risk and capital intensity, despite the fact that the NVIDIA relationship was well received.
#Companies
The comment strengthens **** eX's Starmind concept, which aims to establish AI data centers in orbit rather than on the ground. The first satellite, named Starmind AI1, will carry a **** e-optimized version of NVIDIA's Vera Rubin NVL72 rack-scale system. The standard terrestrial NVL72 combines 72 Rubin GPUs and 36 Vera CPUs, although **** eX and NVIDIA have not disclosed the final configuration of the orbital version. **** e Exploration Technologies Corp. (NASDAQ:SPCX) plans to launch the satellite in the fourth quarter of 2027 and reach substantial scale by 2028. Musk's plan isn't new; during **** eX's first earnings conference as a public company in August, he stated that the company would build exclusively on NVIDIA hardware in the future, calling the Vera Rubin architecture the best available AI computer design.
Musk's central point is that **** e is, in the long run, the most cost-effective area to develop AI computing. He cites solar power availability in orbit as a crucial advantage, and estimates that within two to three years, **** e might become the lowest-cost place for AI computing in general, describing the orbital architecture as simpler, less expensive, denser, and lighter than a standard data-center rack. Not everyone believes the physics and economics will align on Musk's timeframe. Microsoft President Brad Smith has publicly questioned the broader concept, telling reporters that he would be surprised if companies actually transferred computation from land to low-Earth orbit.
For NVIDIA Corporation (NASDAQ:NVDA), the read-through is simple: **** e-based computing would represent a new, if early-stage and speculative, source of demand for its Vera Rubin platform, on top of the company's strong position in terrestrial AI infrastructure. According to some **** yst models, **** eX accounts for approximately 5% of NVIDIA's revenue.
SpaceX's reasoning is more convoluted. The plan is entirely dependent on the success of Starship, **** eX's next-generation rocket system, which still needs to demonstrate its capacity to handle launch frequency and reliability on the scale Musk describes. When Musk said during **** eX's August earnings call that the company would build its future AI infrastructure exclusively on NVIDIA, NVDA shares rose more than 4%, while **** eX's shares fell more than 10% before paring losses, reflecting investor concerns about execution risk and capital intensity, despite the fact that the NVIDIA relationship was well received.
#Companies
12 days ago
The Illinois governor called for federal regulation of AI.
With calls to regulate AI growing, Illinois Gov. JB Pritzker urged Congress to pass federal guardrails on the technology.
“You can't do this state by state. This needs to be a national effort as well as an international endeavor, especially together with our allies, because AI is not going to go away,” Pritzker told ABC “This Week” co-anchor Jonathan Karl in an exclusive interview that aired Sunday.
Pritzker touted legislation he signed in Illinois in July requiring AI companies to conduct annual third-party audits of their safety plans and disclose safety incidents to the state. He urged Congress to make federal regulations a top priority, calling the technology “dangerous on the level of nuclear weapons.”
President Donald Trump has called AI fears a “hoax” and announced he is forming an “AI Force” to accelerate growth in the industry. Pritzker said that approach is a mistake.
#federal #urged #safety
With calls to regulate AI growing, Illinois Gov. JB Pritzker urged Congress to pass federal guardrails on the technology.
“You can't do this state by state. This needs to be a national effort as well as an international endeavor, especially together with our allies, because AI is not going to go away,” Pritzker told ABC “This Week” co-anchor Jonathan Karl in an exclusive interview that aired Sunday.
Pritzker touted legislation he signed in Illinois in July requiring AI companies to conduct annual third-party audits of their safety plans and disclose safety incidents to the state. He urged Congress to make federal regulations a top priority, calling the technology “dangerous on the level of nuclear weapons.”
President Donald Trump has called AI fears a “hoax” and announced he is forming an “AI Force” to accelerate growth in the industry. Pritzker said that approach is a mistake.
#federal #urged #safety
12 days ago
SEOUL, Sept 20 (Reuters) - North Korea launched two missiles off its eastern coast on Sunday, its second set of tests in roughly a week and days after Pyongyang accused the US of driving tensions on the Korean Peninsula through a series of military drills.
Just three hours after launching a short-range ballistic missile (SRBM) toward the East Sea on Sunday afternoon, North Korea fired another short-range ballistic missile, according to South Korea's defence ministry.
If the subsequent launch is confirmed to be a ballistic missile, it will mark two consecutive ballistic missile tests by North Korea within a three-hour window.
South Korea's Joint Chiefs of Staff said it detected the first test firing from the Wonsan area around 3 p.m. (0600 GMT), identifying the weapon as a ballistic missile. ***** an's defence ministry also said it appeared to be a ballistic missile.
Japanese public broadcaster NHK said the projectile had come down outside ***** an's exclusive economic zone.
#sunday
Just three hours after launching a short-range ballistic missile (SRBM) toward the East Sea on Sunday afternoon, North Korea fired another short-range ballistic missile, according to South Korea's defence ministry.
If the subsequent launch is confirmed to be a ballistic missile, it will mark two consecutive ballistic missile tests by North Korea within a three-hour window.
South Korea's Joint Chiefs of Staff said it detected the first test firing from the Wonsan area around 3 p.m. (0600 GMT), identifying the weapon as a ballistic missile. ***** an's defence ministry also said it appeared to be a ballistic missile.
Japanese public broadcaster NHK said the projectile had come down outside ***** an's exclusive economic zone.
#sunday
12 days ago
Meta Platforms, Inc. (NASDAQ:META) is taking another step toward monetizing artificial intelligence beyond its core advertising business. On September 9, the company acquired AI startup Stilla.ai.
The acquisition will strengthen the company's agentic AI capabilities as it moves to capitalize on growing demand for AI agents that can handle business transactions. Plans are underway to integrate Stilla.ai's team and technology into Meta Business Agent, which already helps businesses interact with customers across various platforms.
Stilla.ai's technology could help Meta's Business Agent enable more sophisticated interactions between customers and AI agents across its messaging platforms. In the long term, customers could use AI agents to inquire about products, discuss pricing, and potentially complete purchases without leaving Meta's ecosystem.
Such capabilities could result in new monetization opportunities as the company faces increasing pressure to generate returns from its substantial artificial intelligence investments. Rather than relying exclusively on AI to improve advertising efficiency, Meta could use AI to facilitate transactions and capture value from the commercial activity taking place across its platforms.
The acquisition could help the company build an AI-driven commerce layer across its massive messaging ecosystem. The company has access to billions of users across Facebook, Instagram, Messenger, and WhatsApp, while millions of businesses already use its platforms to communicate with customers.
#customers #agents
The acquisition will strengthen the company's agentic AI capabilities as it moves to capitalize on growing demand for AI agents that can handle business transactions. Plans are underway to integrate Stilla.ai's team and technology into Meta Business Agent, which already helps businesses interact with customers across various platforms.
Stilla.ai's technology could help Meta's Business Agent enable more sophisticated interactions between customers and AI agents across its messaging platforms. In the long term, customers could use AI agents to inquire about products, discuss pricing, and potentially complete purchases without leaving Meta's ecosystem.
Such capabilities could result in new monetization opportunities as the company faces increasing pressure to generate returns from its substantial artificial intelligence investments. Rather than relying exclusively on AI to improve advertising efficiency, Meta could use AI to facilitate transactions and capture value from the commercial activity taking place across its platforms.
The acquisition could help the company build an AI-driven commerce layer across its massive messaging ecosystem. The company has access to billions of users across Facebook, Instagram, Messenger, and WhatsApp, while millions of businesses already use its platforms to communicate with customers.
#customers #agents
12 days ago
Tegan Lecheler, founder and director of Mothers & Infant Cash Coalition, told Fox News Digital its support for cash ****** istance has been praised by the right.
Although guaranteed income programs have faced partisan pushback nationwide since gaining national traction in 2018, a growing faction of conservatives is finding common ground with direct cash initiatives centered on mothers and newborns.
According to Tegan Lecheler, national program director for the Mother and Infant Cash Coalition (MICC), the "common-sense" nature of early childhood cash transfers has prompted conservative lawmakers and advocates to reach out to her organization in support.
"I think we're in a really polarized time politically right now," Lecheler told Fox News Digital. "We are not a political organization and want to work to improve families' outcomes. We believe an effective strategy for doing that is to build a big tent – a wide tent with a lot of people underneath it."
EXCLUSIVE: PENCE GROUP KNOCKS VANCE PLAN TO PAY STAY-AT-HOME PARENTS UP TO $9K PER CHILD
#support
Although guaranteed income programs have faced partisan pushback nationwide since gaining national traction in 2018, a growing faction of conservatives is finding common ground with direct cash initiatives centered on mothers and newborns.
According to Tegan Lecheler, national program director for the Mother and Infant Cash Coalition (MICC), the "common-sense" nature of early childhood cash transfers has prompted conservative lawmakers and advocates to reach out to her organization in support.
"I think we're in a really polarized time politically right now," Lecheler told Fox News Digital. "We are not a political organization and want to work to improve families' outcomes. We believe an effective strategy for doing that is to build a big tent – a wide tent with a lot of people underneath it."
EXCLUSIVE: PENCE GROUP KNOCKS VANCE PLAN TO PAY STAY-AT-HOME PARENTS UP TO $9K PER CHILD
#support
12 days ago
Updated Sept. 18, 2026 4:59 pm ET
Listen
(3 min)
The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1357 ET – Hyperliquid’s HYPE token rises 6.7% to $90.83 after the exchange announced that it would enable direct borrowing on its platform. HYPE hit a record $92.43 earlier in the session. Hyperliquid says that it will let users supply HYPE or BTC as collateral for loans, offering 65% and 50% loan-to-value, respectively, according to a statement on its website. The HYPE token has gained 30% in the past two months alone.(kirk.maltaiswsj.com)
#market
Listen
(3 min)
The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1357 ET – Hyperliquid’s HYPE token rises 6.7% to $90.83 after the exchange announced that it would enable direct borrowing on its platform. HYPE hit a record $92.43 earlier in the session. Hyperliquid says that it will let users supply HYPE or BTC as collateral for loans, offering 65% and 50% loan-to-value, respectively, according to a statement on its website. The HYPE token has gained 30% in the past two months alone.(kirk.maltaiswsj.com)
#market
12 days ago
Updated Sept. 18, 2026 4:54 pm ET
Listen
(3 min)
The latest Market Talks covering Technology, Media and Telecom. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1320 ET – Recent AI security incidents disclosed by OpenAI are a cause for concern, Microsoft AI CEO Mustafa Suleyman says on CNBC. An OpenAI model seems to have tampered with the log of its chain-of-thought reasoning, which was “modified to leave messages for a future version of itself,” Suleyman says, citing the company’s recent security disclosures. “We don’t know why that is or what’s behind that, but that’s a pretty serious situation.” He praises OpenAI’s disclosure of the incident but says it demonstrates the growing power and capability of leading AI models.(elias.schisgallwsj.com)
#market
Listen
(3 min)
The latest Market Talks covering Technology, Media and Telecom. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1320 ET – Recent AI security incidents disclosed by OpenAI are a cause for concern, Microsoft AI CEO Mustafa Suleyman says on CNBC. An OpenAI model seems to have tampered with the log of its chain-of-thought reasoning, which was “modified to leave messages for a future version of itself,” Suleyman says, citing the company’s recent security disclosures. “We don’t know why that is or what’s behind that, but that’s a pretty serious situation.” He praises OpenAI’s disclosure of the incident but says it demonstrates the growing power and capability of leading AI models.(elias.schisgallwsj.com)
#market
13 days ago
With a dividend yield of 4.3%, Ford (F) is among the highest-yielding constituents of the S&P 500 Index ($SPX). That number would look even more compelling considering Ford's dividend yield is over four times what an average S&P 500 Index constituent pays.
However, a bit of number-crunching tells a different picture. Dividend yield is basically a function of the per-share dividend, which is the numerator in the equation, and the stock price, which is the denominator. Dividend yield rises when the company raises its dividends or the share price falls. More often than not, the latter is true for companies that have a very high dividend yield.
Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market ****** ysis you won't find anywhere else.
The S&P 500's dividend yield is near its historical lows. Two factors can be blamed for the dip in the world's most popular index's dividend yield. First, tech companies' share in the market-cap-weighted index has soared amid the artificial intelligence (AI) driven rally. Mega-cap tech companies are known to be frugal with dividends, and their rising weightage in the index pulls down its dividend yield. Second, while the annualized dividend per share of the S&P 500 has continued to rise over the years, the increase has been much lower compared to the surge in stock prices.
In contrast, Ford's quarterly dividend has been static since July 2022, when the company raised the payout by 50% to $0.15. Notably, while Ford paid special dividends in the preceding three years to reach its payout targets, it hasn't raised its payout for over four years. Its dividend yield is still high because of its underperforming stock, which has essentially gone nowhere in the last five years and trades 46% below its October 2022 highs.
#Dividend #yield #Share #dividends
However, a bit of number-crunching tells a different picture. Dividend yield is basically a function of the per-share dividend, which is the numerator in the equation, and the stock price, which is the denominator. Dividend yield rises when the company raises its dividends or the share price falls. More often than not, the latter is true for companies that have a very high dividend yield.
Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market ****** ysis you won't find anywhere else.
The S&P 500's dividend yield is near its historical lows. Two factors can be blamed for the dip in the world's most popular index's dividend yield. First, tech companies' share in the market-cap-weighted index has soared amid the artificial intelligence (AI) driven rally. Mega-cap tech companies are known to be frugal with dividends, and their rising weightage in the index pulls down its dividend yield. Second, while the annualized dividend per share of the S&P 500 has continued to rise over the years, the increase has been much lower compared to the surge in stock prices.
In contrast, Ford's quarterly dividend has been static since July 2022, when the company raised the payout by 50% to $0.15. Notably, while Ford paid special dividends in the preceding three years to reach its payout targets, it hasn't raised its payout for over four years. Its dividend yield is still high because of its underperforming stock, which has essentially gone nowhere in the last five years and trades 46% below its October 2022 highs.
#Dividend #yield #Share #dividends
13 days ago
Updated Sept. 17, 2026 4:53 pm ET
Listen
(3 min)
The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1006 ET – U.S. pending home sales fell 3.5% week-over-week to their lowest level in almost three years, Redfin says. Declining homebuying demand is giving buyers breathing room. It means less competition and more room to negotiate for the house hunters who are still shopping. New listings fell slightly, -0.5%, from a week earlier, but they’re still up 1.5% year-over-year, and there are still hundreds of thousands more home sellers than buyers in the market. More homes on the market equals less pressure on buyers to rush into a decision or pay more than they want. Home-sale prices are holding steady. The median home-sale price rose 2% year-over-year. That stability means prices aren’t soaring, and that sellers aren’t in immediate danger of home values dropping. (chris.wackwsj.com)
#still #fell #means
Listen
(3 min)
The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1006 ET – U.S. pending home sales fell 3.5% week-over-week to their lowest level in almost three years, Redfin says. Declining homebuying demand is giving buyers breathing room. It means less competition and more room to negotiate for the house hunters who are still shopping. New listings fell slightly, -0.5%, from a week earlier, but they’re still up 1.5% year-over-year, and there are still hundreds of thousands more home sellers than buyers in the market. More homes on the market equals less pressure on buyers to rush into a decision or pay more than they want. Home-sale prices are holding steady. The median home-sale price rose 2% year-over-year. That stability means prices aren’t soaring, and that sellers aren’t in immediate danger of home values dropping. (chris.wackwsj.com)
#still #fell #means
13 days ago
Ascendis Pharma A/S (NASDAQ:ASND) announced on September 14 that it will regain exclusive rights to develop, manufacture, and commercialize TransCon products in metabolic and cardiovascular diseases following the termination of its collaboration with Novo Nordisk A/S (NYSE:NVO).
The rights include once-monthly TransCon Semaglutide, an investigational long-acting prodrug of semaglutide intended for obesity and type 2 diabetes. Neither party will have continuing financial obligations to the other. Once termination becomes effective and the rights revert, management plans to initiate multiple programs across rare and large indications.
The investment question is whether greater control over future products can justify the resources needed to develop them.
Ascendis Pharma A/S (NASDAQ:ASND) would regain flexibility over which indications to pursue, how quickly to advance candidates, and whether to seek another partner. Successful independent development could retain more of a product's commercial economics, while a new collaboration could provide another way to share costs and risk.
Monthly dosing offers a clear development objective. If clinical studies demonstrate effective treatment with acceptable tolerability, fewer injections could make long-term therapy more convenient. That potential benefit would matter most if it helps patients stay on treatment without sacrificing outcomes.
#ascendis #pharma #asnd #regain
The rights include once-monthly TransCon Semaglutide, an investigational long-acting prodrug of semaglutide intended for obesity and type 2 diabetes. Neither party will have continuing financial obligations to the other. Once termination becomes effective and the rights revert, management plans to initiate multiple programs across rare and large indications.
The investment question is whether greater control over future products can justify the resources needed to develop them.
Ascendis Pharma A/S (NASDAQ:ASND) would regain flexibility over which indications to pursue, how quickly to advance candidates, and whether to seek another partner. Successful independent development could retain more of a product's commercial economics, while a new collaboration could provide another way to share costs and risk.
Monthly dosing offers a clear development objective. If clinical studies demonstrate effective treatment with acceptable tolerability, fewer injections could make long-term therapy more convenient. That potential benefit would matter most if it helps patients stay on treatment without sacrificing outcomes.
#ascendis #pharma #asnd #regain
14 days ago
Listen
(4 min)
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1528 ET – Q/C Technologies shares mostly rebounded from a 67% drop Monday and a 52-week low Tuesday, more than doubling late Wednesday. The optical-computing company late Friday disclosed that consulting agreements with an entity affiliated with Martin Shkreli and with OpenAI scientist Chelsea Voss were mutually terminated. Voss also resigned from the board. Earlier Wednesday, adviser James Altucher posted on X about the company’s AI-powered platform for chip design, which coincided with an intraday peak in the company’s share price. Shares were recently at $1.06, up 139%, amid very volatile trading and still below Friday’s close of $1.71. (josh.beckermanwsj.com)
#voss
(4 min)
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1528 ET – Q/C Technologies shares mostly rebounded from a 67% drop Monday and a 52-week low Tuesday, more than doubling late Wednesday. The optical-computing company late Friday disclosed that consulting agreements with an entity affiliated with Martin Shkreli and with OpenAI scientist Chelsea Voss were mutually terminated. Voss also resigned from the board. Earlier Wednesday, adviser James Altucher posted on X about the company’s AI-powered platform for chip design, which coincided with an intraday peak in the company’s share price. Shares were recently at $1.06, up 139%, amid very volatile trading and still below Friday’s close of $1.71. (josh.beckermanwsj.com)
#voss
14 days ago
Listen
(4 min)
The latest Market Talks covering Basic Materials. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1444 ET – Precious metals are giving back gains after the Federal Reserve raised interest rates as expected. Equities have taken the news “relatively well,” but “evidence of the Fed’s hawkishness is in the slightly firmer U.S. dollar and lower gold price,” Capital.com senior financial market ***** yst Kyle Rodda says in a note. “A special focus will be on the shape of the yield curve too as markets ***** s what impact policy is having on long-term inflation expectations.” Gold for December delivery is off 0.1% at $4,327.10 a troy ounce and silver up 0.7% at $64.33 a troy ounce. (anthony.harrupwsj.com)
#ounce #listen #jones
(4 min)
The latest Market Talks covering Basic Materials. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
1444 ET – Precious metals are giving back gains after the Federal Reserve raised interest rates as expected. Equities have taken the news “relatively well,” but “evidence of the Fed’s hawkishness is in the slightly firmer U.S. dollar and lower gold price,” Capital.com senior financial market ***** yst Kyle Rodda says in a note. “A special focus will be on the shape of the yield curve too as markets ***** s what impact policy is having on long-term inflation expectations.” Gold for December delivery is off 0.1% at $4,327.10 a troy ounce and silver up 0.7% at $64.33 a troy ounce. (anthony.harrupwsj.com)
#ounce #listen #jones
15 days ago
Kohberger is working to undo his guilty plea to the 2022 Idaho murders.
The family of Bryan Kohberger is supporting his efforts to challenge his 2025 conviction, saying in a statement exclusive to ABC News, "Our full support of Bryan’s decision to pursue post-conviction relief does not come from a place of disregard.”
Kohberger, who is currently serving four consecutive life sentences for killing four college students in Idaho, said in his petition that the circumstances of his plea deal are now suspect because, among other things, he was “convinced to falsely confess” to a crime he says he did not commit.
“My actual innocence is my truth, and the plea, hinged on by false promises and blatant disinformation, MUST be withdrawn,” he said in a statement to the New York Times last month.
Kohberger's family told ABC News that they did not want their support of their son "to compound the unimaginable grief the families have borne so courageously."
#plea #conviction #four
The family of Bryan Kohberger is supporting his efforts to challenge his 2025 conviction, saying in a statement exclusive to ABC News, "Our full support of Bryan’s decision to pursue post-conviction relief does not come from a place of disregard.”
Kohberger, who is currently serving four consecutive life sentences for killing four college students in Idaho, said in his petition that the circumstances of his plea deal are now suspect because, among other things, he was “convinced to falsely confess” to a crime he says he did not commit.
“My actual innocence is my truth, and the plea, hinged on by false promises and blatant disinformation, MUST be withdrawn,” he said in a statement to the New York Times last month.
Kohberger's family told ABC News that they did not want their support of their son "to compound the unimaginable grief the families have borne so courageously."
#plea #conviction #four
15 days ago
EXCLUSIVE
PUBLISHED
SEP 16, 2026 AT 06:32 PM EDT
Vice President JD Vance discussed the White House's message ahead of the midterm elections on the All-In Podcast, saying, "There’s a lot of good that’s been done, but there’s a lot of work left to do," adding that the American people should "give us another chance" in November.
Vance's remarks come amid challenges both Republicans and the White House have faced in recent polling less than 50 days before Election Day. Numerous polls have signaled a more favorable environment for Democrats, who lead the generic ballot and have shown improvement in battleground contests.
#white #vance #republicans
PUBLISHED
SEP 16, 2026 AT 06:32 PM EDT
Vice President JD Vance discussed the White House's message ahead of the midterm elections on the All-In Podcast, saying, "There’s a lot of good that’s been done, but there’s a lot of work left to do," adding that the American people should "give us another chance" in November.
Vance's remarks come amid challenges both Republicans and the White House have faced in recent polling less than 50 days before Election Day. Numerous polls have signaled a more favorable environment for Democrats, who lead the generic ballot and have shown improvement in battleground contests.
#white #vance #republicans
15 days ago
Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies' experimental Lyme disease vaccine candidate, and will now begin the official review.
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#vaccine #pfizer #NYSE
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#vaccine #pfizer #NYSE
15 days ago
Meta (META) on Tuesday officially unveiled its Meta One subscription service as part of the company's effort to further monetize its enormous AI spending and diversify its revenue stream.
The plans, which start at $2.99 per month for single-product plans, $7.99 for individual bundles, and $14.99 for creator and business bundles, provide a number of features for users looking to get more out of their Instagram, Facebook, and WhatsApp accounts.
Instagram Plus and Facebook Plus allow users to keep their stories up for 48 hours instead of 24, send animated super reactions and super hearts to stories, preview stories without showing up as a viewer in other users' lists, and more.
WhatsApp Plus lets you share exclusive stickers, get exclusive ringtones for contacts, and pin up to 20 different chats.
#meta #users #Instagram #plans
The plans, which start at $2.99 per month for single-product plans, $7.99 for individual bundles, and $14.99 for creator and business bundles, provide a number of features for users looking to get more out of their Instagram, Facebook, and WhatsApp accounts.
Instagram Plus and Facebook Plus allow users to keep their stories up for 48 hours instead of 24, send animated super reactions and super hearts to stories, preview stories without showing up as a viewer in other users' lists, and more.
WhatsApp Plus lets you share exclusive stickers, get exclusive ringtones for contacts, and pin up to 20 different chats.
#meta #users #Instagram #plans
15 days ago
Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies' experimental Lyme disease vaccine candidate, and will now begin the official review.
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#disease
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#disease
